Endotoxemia-induced protein C surge protects mice against venous thrombosis based on transient lowering of natural anticoagulants

Blood Coagul Fibrinolysis. 2025 Dec 1;36(8):381-385. doi: 10.1097/MBC.0000000000001392. Epub 2025 Oct 22.

Abstract

Immunothrombosis is the process by which inflammatory stimuli promote coagulation and thrombus formation. Bacterial sepsis is a well established risk factor for venous thrombosis, and numerous experimental studies have shown that sepsis indeed enhances thrombotic responses. In this study, we aimed to investigate the impact of endotoxemia - induced by either lipopolysaccharides or α-toxin - on venous thrombosis development in mice. Venous thrombosis was induced using a model based on siRNA-mediated transient inhibition of the natural anticoagulants - protein C (PC) and anti-thrombin (AT). Unexpectedly, endotoxemia attenuated rather than promoted venous thrombus formation. This counterintuitive finding appears to be explained by a transient increase in circulating protein C levels following endotoxemia. As our venous thrombosis mouse model strongly depends on the level of reduced protein C activity, this endotoxemia-induced elevation interfered with the intended prothrombotic conditions and compromised comparability between experimental groups. These results highlight the context-dependent effects of bacterial sepsis on venous thrombosis and underscore the importance of rigorous model validation in (immuno)thrombosis research.

Keywords: endotoxemia; mouse models; venous thrombosis.

MeSH terms

  • Animals
  • Anticoagulants*
  • Disease Models, Animal
  • Endotoxemia* / blood
  • Endotoxemia* / complications
  • Lipopolysaccharides
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Protein C* / metabolism
  • Venous Thrombosis* / blood
  • Venous Thrombosis* / etiology
  • Venous Thrombosis* / pathology
  • Venous Thrombosis* / prevention & control

Substances

  • Protein C
  • Anticoagulants
  • Lipopolysaccharides